Hedge fund manager Barton Biggs and contrarian investor Marc Faber both said in an interview with Bloomberg Television that the dollar and the U.S. equity market may gain up to 10% in the next two years. "History would suggest that after such a severe economic shock like we've just had that the odds are that we're going to have a pretty good burst of growth in 2010, 2011," Biggs said. "I don't see any reason why we can't have a further rally in the dollar and a further rally in stocks.
Yahoo is committed to inspiring and entertaining its 800 million users worldwide with trusted news and original content, delivered in new ways through innovative product experiences. The company is investing in top talent and leading industry voices, with recent hires including tech columnist David Pogue, Yahoo News editor uk finance news in chief Megan Liberman, and national political columnist Matt Bai. Yahoo continues to work closely with partners like ABC News to cover live events through its growing digital video network.Yahoo continues to work closely with partners like ABC News to cover live events through its growing digital video network.
Membership of social network sites has reached a plateau for Europe's networked elite in 2013 with 85% claiming to be a member of at least one network (dropping slightly from 87% in 2012). After consistent year-on-year growth between 2010 and 2012, Facebook has now stabilised at 61% (vs. 60% in 2012). LinkedIn membership increased dramatically to 58% in 2013 (45% in 2012). Twitter increased from 38% in 2012 to 43% in 2013. Growth for Twitter and LinkedIn is partly being driven by the increase in take up among existing Facebook users.
New standards concerning access to key medicines appear to be equally problematic for many nations. The Obama administration is insisting on mandating new intellectual property rules in the treaty that would grant pharmaceutical companies long-term monopolies on new medications. As a result, companies can charge high prices uk finance news without regard to competition from generic providers. The result, public health experts have warned , would be higher prices around the world, and lack of access to life-saving drugs in poor countries. Nearly every intellectual property issue in the November chart is opposed by a broad majority of the 12 nations.
Australia and New Zealand have medical boards that allow the government to reject expensive new drugs for the public health system, or negotiate lower prices with drug companies that own patents on them. If a new drug does not offer sufficient benefits over existing generic drugs, the boards can reject spending taxpayer money on the new medicines. They can also refuse to pay high prices for new drugs. The Obama administration has been pushing to ban these activities by national boards, which would lock in big profits for U.S. drug companies. more information
Related Articles -
uk, business, news,